Effect of cancer cachexia on the outcomes of first-line chemotherapy in pancreatic cancer: A claims database study

被引：0
|
作者：
Furuse, Junji [1 ]
Osugi, Fumihiko [2 ]
Machii, Koji [2 ]
Niibe, Koji [2 ]
Endo, Toshimitsu [2 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[2] Ono Pharmaceut Co Ltd, Ono, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO61-3
引用
收藏
页码：S1435 / S1435
页数：1
相关论文
共 50 条
  • [21] First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapyvscombination chemotherapy
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (18) : 4022 - 4033
  • [22] First-line chemotherapy in advanced ovarian cancer
    Colombo, N
    Parma, G
    Caspani, G
    Donesana, P
    Marinetti, E
    Mangioni, C
    TUMORI JOURNAL, 1999, 85 (03): : S23 - S26
  • [23] Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy
    McAndrew, Erin N.
    Zhang, Hanbo
    Lambert, Pascal
    Rittberg, Rebekah
    Dawe, David E.
    Kim, Christina A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (02): : 55 - 60
  • [24] Treatment patterns, toxicity, and outcomes of elderly patients with advanced pancreatic cancer receiving first-line chemotherapy.
    Kudlovich, Robert
    Zhang, Hanbo
    Kim, Christina
    Dawe, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [25] A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic Cancer
    Yi, Jun Ho
    Lee, Jeeyun
    Park, Se Hoon
    Lee, Kyu Taek
    Lee, Jong Kyun
    Lee, Kwang Hyuck
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin-Seok
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Keunchil
    Park, Joon Oh
    ONCOLOGY, 2011, 80 (3-4) : 175 - 180
  • [26] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [27] Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
    Cartwright T.H.
    Parisi M.
    Espirito J.L.
    Wilson T.W.
    Pelletier C.
    Patel M.
    Babiker H.M.
    Drugs - Real World Outcomes, 2018, 5 (3) : 149 - 159
  • [28] Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
    Arlen, Aimee Ginsburg
    Cartwright, Thomas H.
    Wilfong, Lalan S.
    Hoverman, J. Russell
    Nelson, Greg C.
    Turnwald, Brian
    Beveridge, Roy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Beyond first-line chemotherapy for advanced pancreatic cancer:An expanding array of therapeutic options?
    Evan J Walker
    Andrew H Ko
    World Journal of Gastroenterology, 2014, (09) : 2224 - 2236
  • [30] FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer
    Giuliani, Jacopo
    Bonetti, Andrea
    PANCREATOLOGY, 2019, 19 (02) : 325 - 330
12345